Remifemin
This article was originally published in The Tan Sheet
Executive Summary
GSK did not provide International Menopause Society with unrestricted educational grant to create Powering Informed Choices Initiative, which promotes firm's Remifemin, as stated in 1"The Tan Sheet" Oct. 29, p. 13...
You may also be interested in...
Menopause Herbals Viewed Warily By Patients & Doctors, Surveys Show
Soy, vitamin E and black cohosh are the dietary supplement ingredients that doctors feel most comfortable recommending to their patients for menopause, according to a recent Southern California University of Health Sciences survey.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.